The Middle EAST Liposome Drug Delivery Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 1.20 billion by 2034, registering a CAGR of 10.0%. This growth trajectory is underpinned by increasing investments in pharmaceutical research and development, rising prevalence of chronic diseases, and the growing demand for targeted drug delivery systems. The liposome technology...